Chenguang Biotech (300138.SZ) released its report for the first quarter of 2024. The company's revenue was 17.3...
According to the Zhitong Finance App, Chenguang Biotech (300138.SZ) released its report for the first quarter of 2024. The company's revenue was 1,732 billion yuan, a year-on-year decrease of 4.71%. Net profit attributable to shareholders of listed companies was 385.919 million yuan, a year-on-year decrease of 71.42%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 484.8872 million yuan, a year-on-year decrease of 58.38%. Basic earnings per share were $0.0725.